SARS-CoV-2 nsp13-IN-2

• UNSPSC Description:

  SARS-CoV-2 nsp13-IN-2 (Compound C2) is a SARS-CoV-2 non-structural protein 13 (nsp13) small-molecule inhibitor with an IC50 of 42 μM against nsp13 ssDNA+ ATPase[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-nsp13-in-2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=CC=C(C=C1)N/C(N)=N/C2=NC(C=C(CSC3=NC4=C(S3)C=CC=C4)N2)=O

• Molecular Weight:

  422.53

• References & Citations:

  [1]Yazdi AK, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis. 2022 Jul 13.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  522660-61-3